Boston Financial Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $10.3M | Sell |
19,879
-157
| -0.8% | -$86.3K | 0.31% | 71 |
|
|
2024
Q3 | $12.4M | Sell |
20,036
-473
| -2% | -$280K | 0.37% | 66 |
|
|
2024
Q2 | $11.3M | Sell |
20,509
-97
| -0.5% | -$55.6K | 0.36% | 66 |
|
|
2024
Q1 | $12M | Buy |
20,606
+376
| +2% | +$211K | 0.38% | 63 |
|
|
2023
Q4 | $10.7M | Buy |
20,230
+591
| +3% | +$286K | 0.36% | 64 |
|
|
2023
Q3 | $9.94M | Sell |
19,639
-560
| -3% | -$298K | 0.37% | 64 |
|
|
2023
Q2 | $10.5M | Buy |
20,199
+1,022
| +5% | +$552K | 0.38% | 66 |
|
|
2023
Q1 | $11.1M | Sell |
19,177
-1,125
| -6% | -$634K | 0.43% | 60 |
|
|
2022
Q4 | $11.2M | Buy |
20,302
+847
| +4% | +$449K | 0.45% | 61 |
|
|
2022
Q3 | $9.87M | Buy |
19,455
+5,995
| +45% | +$3.35M | 0.43% | 61 |
|
|
2022
Q2 | $7.31M | Sell |
13,460
-120
| -0.9% | -$66.1K | 0.32% | 67 |
|
|
2022
Q1 | $8.02M | Sell |
13,580
-164
| -1% | -$94.2K | 0.3% | 70 |
|
|
2021
Q4 | $9.17M | Sell |
13,744
-260
| -2% | -$162K | 0.33% | 64 |
|
|
2021
Q3 | $8M | Sell |
14,004
-344
| -2% | -$189K | 0.33% | 64 |
|
|
2021
Q2 | $7.24M | Sell |
14,348
-474
| -3% | -$224K | 0.29% | 65 |
|
|
2021
Q1 | $6.76M | Sell |
14,822
-80
| -0.5% | -$38.2K | 0.3% | 67 |
|
|
2020
Q4 | $6.94M | Sell |
14,902
-341
| -2% | -$160K | 0.32% | 65 |
|
|
2020
Q3 | $6.73M | Sell |
15,243
-265
| -2% | -$109K | 0.33% | 64 |
|
|
2020
Q2 | $5.62M | Sell |
15,508
-288
| -2% | -$96.5K | 0.3% | 67 |
|
|
2020
Q1 | $4.48M | Buy |
15,796
+939
| +6% | +$296K | 0.29% | 72 |
|
|
2019
Q4 | $4.83M | Sell |
14,857
-33
| -0.2% | -$10K | 0.26% | 78 |
|
|
2019
Q3 | $4.34M | Sell |
14,890
-320
| -2% | -$91.6K | 0.25% | 90 |
|
|
2019
Q2 | $4.47M | Sell |
15,210
-98
| -0.6% | -$27K | 0.26% | 89 |
|
|
2019
Q1 | $4.19M | Sell |
15,308
-994
| -6% | -$247K | 0.25% | 93 |
|
|
2018
Q4 | $3.65M | Sell |
16,302
-304
| -2% | -$71.3K | 0.25% | 95 |
|
|
2018
Q3 | $4.05M | Sell |
16,606
-462
| -3% | -$106K | 0.24% | 102 |
|
|
2018
Q2 | $3.54M | Buy |
17,068
+27
| +0.2% | +$5.73K | 0.24% | 104 |
|
|
2018
Q1 | $3.52M | Sell |
17,041
-1,353
| -7% | -$284K | 0.24% | 108 |
|
|
2017
Q4 | $3.49M | Sell |
18,394
-703
| -4% | -$135K | 0.23% | 113 |
|
|
2017
Q3 | $3.61M | Sell |
19,097
-70
| -0.4% | -$12.7K | 0.26% | 112 |
|
|
2017
Q2 | $3.34M | Buy |
19,167
+420
| +2% | +$70.5K | 0.24% | 120 |
|
|
2017
Q1 | $2.88M | Sell |
18,747
-1,226
| -6% | -$187K | 0.21% | 128 |
|
|
2016
Q4 | $2.82M | Sell |
19,973
-410
| -2% | -$60.4K | 0.22% | 136 |
|
|
2016
Q3 | $3.24M | Sell |
20,383
-1,355
| -6% | -$209K | 0.26% | 123 |
|
|
2016
Q2 | $3.21M | Sell |
21,738
-220
| -1% | -$32.5K | 0.26% | 127 |
|
|
2016
Q1 | $3.11M | Sell |
21,958
-1,448
| -6% | -$194K | 0.47% | 76 |
|
|
2015
Q4 | $3.32M | Sell |
23,406
-4,542
| -16% | -$606K | 0.48% | 76 |
|
|
2015
Q3 | $3.42M | Buy |
27,948
+486
| +2% | +$63.3K | 0.48% | 72 |
|
|
2015
Q2 | $3.56M | Sell |
27,462
-1,339
| -5% | -$175K | 0.46% | 73 |
|
|
2015
Q1 | $3.87M | Buy |
28,801
+5,562
| +24% | +$717K | 0.48% | 69 |
|
|
2014
Q4 | $2.91M | Buy |
23,239
+1,105
| +5% | +$134K | 0.37% | 88 |
|
|
2014
Q3 | $2.69M | Buy |
22,134
+1,735
| +9% | +$211K | 0.35% | 90 |
|
|
2014
Q2 | $2.41M | Sell |
20,399
-108
| -0.5% | -$12.7K | 0.32% | 96 |
|
|
2014
Q1 | $2.47M | Sell |
20,507
-926
| -4% | -$110K | 0.33% | 86 |
|
|
2013
Q4 | $2.39M | Buy |
21,433
+675
| +3% | +$67.1K | 0.33% | 87 |
|
|
2013
Q3 | $1.91M | Sell |
20,758
-995
| -5% | -$90K | 0.29% | 97 |
|
|
2013
Q2 | $1.84M | Buy |
+21,753
| New | +$1.81M | 0.28% | 95 |
|
Other funds holding TMO
Boston Financial Management's TMO Position: Q4 2024 in Review
Boston Financial Management reduced its Thermo Fisher Scientific (TMO) stake by 0.78% in Q4 2024, selling an estimated $86.3K and leaving 19,879 shares worth $10.3M. The position accounts for 0.31% of the portfolio, ranked #71.
Boston Financial Management first reported a position in TMO in Q2 2013 and has held it in 47 quarters since. The position peaked at $12.4M in Q3 2024. 2,617 funds tracked by Wall St. Rank hold TMO as of Q4 2024.
- Boston Financial Management held 19,879 shares of Thermo Fisher Scientific worth $10.3M as of Q4 2024.
- Boston Financial Management sold 157 Thermo Fisher Scientific shares in Q4 2024, an estimated $86.3K.
- Thermo Fisher Scientific made up 0.31% of Boston Financial Management's portfolio in Q4 2024, its #71 holding.
- Boston Financial Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 47 quarters since.
- Boston Financial Management's Thermo Fisher Scientific position peaked at $12.4M in Q3 2024.
- 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.
Based on Boston Financial Management's 13F filing for Q4 2024, filed 3 Feb 2025.